GENEVA, 15 July 2025–Lenacapavir–a long-acting, six-monthly injectable antiretroviral medicine manufactured by Gilead Sciences–is now recommended by the World Health Organization as an additional HIV ...

In January the Government of Fiji declared an HIV outbreak in response to the sharp increase in new diagnoses. Although its HIV Surge Strategy seeks to rapidly expand HIV testing and treatment, most ...

UNAIDS emphasizes that every dollar invested in the HIV response not only saves lives but strengthens health systems and promotes broader development goals. Since the start of the epidemic, 26.9 ...

A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large ...

New HIV infections have been reduced by 40% since 2010, and 4.4 million children have been protected from acquiring HIV since 2000. More than 26 million lives have been saved. The response to HIV is ...

Borey and Sophia are among the first clients in Cambodia to begin long-acting injectable Cabotegravir (CAB-LA), a PrEP ...

GENEVA, 4 July 2025— It is with profound sadness that UNAIDS learns of the passing of the former Deputy President of the ...

A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large ...

GENEVA, 25 June 2025 — UNAIDS and Flanders have strengthened their joint efforts to combat the AIDS pandemic in Africa by ...

UNAIDS uses ‘cost of inaction’ as an indicator of the negative impact on the lives of people and communities of not investing resources to end AIDS. This issue is particularly significant with regard ...

Countries are continuing to adapt to the recent cuts to US funding for the global HIV response. The impacts of HIV service disruptions are being more clearly understood as more granular information ...